C12N 2760/18444
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2760/18444 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 8
- Assignees
- 9
- Inventors
- 24
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases27 Jan 2026US 12,533,404 B2Centre National De La Recherche Scientifique
- Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof1 Nov 2022US 11,484,588 B1Qingdao Harwars Biology Group Ltd.
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases1 Jun 2021US 11,020,473 B2Centre National De La Recherche Scientifique
- Recombinant measles virus expressing chikungunya virus polypeptides and their applications23 May 2017US 9,655,961 B2Centre National De La Recherche Scientifique
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases6 Aug 2026US 2026/0224687 A1Centre National De La Recherche Scientifique
- Rna virus-derived chimeric envelope protein and rna virus vector having same6 Nov 2025US 2025/0340899 A1Tokiwa-Bio Inc.
- Method for producing stem cells and method for producing somatic cells15 Jun 2023US 2023/0183653 A1I Peace, Inc.
- Recombinant measles virus expressing proteins of a plasmodium parasite and their applications15 Jun 2023US 2023/0183739 A1
- Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof13 Oct 2022US 2022/0323571 A1Qingdao Harwars Biomedicine Technology Co., Ltd.
Most cited
By later US patents
- Recombinant measles virus expressing chikungunya virus polypeptides and their applications2US 9,655,961 B2Centre National De La Recherche Scientifique · 2017
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases1US 11,020,473 B2Centre National De La Recherche Scientifique · 2021